Refine by
Diabetic Nephropathy Suppliers & Manufacturers
7 companies found
Manufacturerbased inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
Inversago Pharma Inc. is focused on the development of peripherally-acting CB1 receptor (CB1) inverse agonists for the treatment of diabetic nephropathy, NASH, type 1 diabetes and Prader-Willi ...
Manufacturerbased inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Manufacturerbased inSeoul, SOUTH KOREA
RheoMeditech Inc., founded in 2003, specializes in blood test in-vitro diagnostic device and has developed by publishing a number of technical and clinical papers to the international Association. RheoMeditech Inc. is a leading manufacturer of wide ...
Manufacturerbased inGunpo-si, SOUTH KOREA
DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...
Manufacturerbased inPescantina (VR), ITALY
We initiate and implement projects for human health. Our products are the result of many years of research and development, experience in the field of plant biochemistry and other natural components. We examine medicinal and endemic plants from all ...
Manufacturerbased inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
Manufacturerbased inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...